Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease

被引:12
作者
Li, Shaobo [1 ]
Lu, Jing [2 ]
Gu, Geng [2 ]
Bai, Wenkun [3 ]
Ye, Yafen [1 ]
Bao, Yuqian [1 ]
Yu, Haoyong [1 ]
Han, Junfeng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Key Lab Diabet M, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ultrasound Med, Shanghai Inst Ultrasound Med, Shanghai, Peoples R China
关键词
biomarker; disease progression; non-alcoholic fatty liver disease; psoas muscles; visceral obesity; SKELETAL-MUSCLE; ADIPOSE-TISSUE; SARCOPENIA; STEATOSIS; FIBROSIS; RISK; MASS; STEATOHEPATITIS; GUIDELINES; DIAGNOSIS;
D O I
10.3389/fphys.2021.664100
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background The simultaneous assessment of visceral adiposity and muscle mass might be useful to monitor the risk of non-alcoholic fatty liver disease (NAFLD) progression in large population. We aimed to investigate the value of serum creatinine-to-cystatin C ratio (CCR) in evaluating these two parameters and predicting liver steatosis and fibrosis. Methods 154 overweight/obese inpatients (49 males, 105 females) scheduled for bariatric surgery and 49 non-overweight/obese volunteers (18 males, 31 females) responded to the hospital advertisement were involved in the cross-sectional study. Liver steatosis and fibrosis were diagnosed with transient elastography (TE). The psoas muscle area (PMA) and visceral fat area (VFA) were measured using magnetic resonance imaging. Results The body mass index, insulin resistance, and lipid profiles showed significant differences between the CCR tertiles. Multiple regression analyses revealed that the CCR was significantly associated with the controlled attenuation parameter (beta = -0.30, P = 0.006 in males; beta = -0.19, P = 0.017 in females) and liver stiffness measurements in males (beta = -0.246, P = 0.044). A low CCR was associated with moderate-to-severe steatosis (P < 0.001), significant liver fibrosis (P < 0.01), and excellent predictive power for these two conditions (P < 0.01). The CCR had a negative correlation with the VFA/PMA ratio (r = -0.584, P < 0.001 in males; r = -0.569, P < 0.001 in females). Conclusions The CCR is a serum marker for muscle-adjusted visceral fat mass, and a low CCR is associated with an increased risk of progressive NAFLD.
引用
收藏
页数:9
相关论文
共 37 条
  • [31] Creatinine/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis
    Tetsuka, Syuichi
    Morita, Mitsuya
    Ikeguchi, Kunihiko
    Nakano, Imaharu
    [J]. NEUROLOGY AND CLINICAL NEUROSCIENCE, 2013, 1 (01): : 32 - 37
  • [32] Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography
    Tsai, Eugenia
    Lee, Tai-Ping
    [J]. CLINICS IN LIVER DISEASE, 2018, 22 (01) : 73 - +
  • [33] Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
    Vilar-Gomez, Eduardo
    Chalasani, Naga
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 305 - 315
  • [34] Cystatin C is a disease-associated protein subject to multiple regulation
    Xu, Yuekang
    Ding, Ying
    Li, Xinchen
    Wu, Xiaobing
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (05) : 442 - 451
  • [35] Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
    Younossi, Zobair M.
    Koenig, Aaron B.
    Abdelatif, Dinan
    Fazel, Yousef
    Henry, Linda
    Wymer, Mark
    [J]. HEPATOLOGY, 2016, 64 (01) : 73 - 84
  • [36] Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
    Younossi, Zobair M.
    Stepanova, Maria
    Negro, Francesco
    Hallaji, Shareh
    Younossi, Youssef
    Lam, Brian
    Srishord, Manirath
    [J]. MEDICINE, 2012, 91 (06) : 319 - 327
  • [37] Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245